Back to News
Market Impact: 0.2
Ekalia takes an important step in the deployment of Astatine-211 in the United States through a collaboration agreement with Telix
Source: globenewswire.com
Healthcare & BiotechTechnology & Innovation
A joint venture between IBA and Framatome plans to use Telix’s capabilities to accelerate Astatine-211 production and availability in the US. The announcement signals a potential expansion in isotope supply, but provides no production targets, timeline, or financial details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
IBAB0.30
TLX0.40
More News
- BlackRock, GIC among investors chasing Indian telecom major Jio's IPO as anchor bids top $26 billion
- Nscale, Anthropic Eye $45 Billion Cloud Deal as AI Trade Rebounds
- Gartner analyst behind tech rout: AI returns are not yet large enough to justify neocloud build-out
- Alibaba Backs Chinese Robovan Maker in $400 Million Fundraising
- X-Energy CEO on Amazon, AEP Nuclear Data Center Deal
- Ukraine’s drones lose their Starlink link above 100 mph. Musk, Rubio and Trump all say it wasn’t them
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- What Exactly Does Post-Training in LLMs and Finance-Focused AI Actually Mean for Asset Managers?
- What Is a Financial Ontology?